- Report
- August 2023
- 145 Pages
Global
From €3022EUR$3,150USD£2,596GBP
- Report
- January 2024
- 244 Pages
Global
€4792EUR$4,995USD£4,116GBP
- Report
- November 2023
- 70 Pages
United States
From €1439EUR$1,500USD£1,236GBP
- Report
- November 2022
- 270 Pages
Global
From €5659EUR$5,899USD£4,861GBP
- Report
- October 2021
- 180 Pages
Global
From €2302EUR$2,400USD£1,978GBP
- Report
- April 2023
- 211 Pages
Global
From €2878EUR$3,000USD£2,472GBP
- Report
- April 2021
- 180 Pages
Global
From €2878EUR$3,000USD£2,472GBP
- Report
- December 2020
- 110 Pages
Global
From €2302EUR$2,400USD£1,978GBP
- Report
- November 2022
- 276 Pages
Global
From €3597EUR$3,750USD£3,090GBP
- Report
- April 2024
- 84 Pages
From €2878EUR$3,000USD£2,472GBP
- Report
- December 2018
- 50 Pages
Global
From €4748EUR$4,950USD£4,079GBP
- Report
- June 2021
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- April 2023
- 120 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- April 2023
- 110 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- April 2023
- 115 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- September 2021
- 189 Pages
Global
From €3055EUR$3,185USD£2,625GBP
€4365EUR$4,550USD£3,750GBP
- Report
- April 2021
Asia Pacific
From €2015EUR$2,100USD£1,731GBP
€2878EUR$3,000USD£2,472GBP
- Report
- August 2020
- 153 Pages
Asia Pacific
From €2015EUR$2,100USD£1,731GBP
€2878EUR$3,000USD£2,472GBP
- Report
- August 2020
- 86 Pages
Europe
From €2015EUR$2,100USD£1,731GBP
€2878EUR$3,000USD£2,472GBP
- Report
- August 2020
- 114 Pages
North America
From €2015EUR$2,100USD£1,731GBP
€2878EUR$3,000USD£2,472GBP
Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more